Confusion Over Anti-Clotting Therapy Hinders Drug-Eluting Stent Rebound
This article was originally published in The Gray Sheet
Executive Summary
Blanket recommendations for one year of dual antiplatelet therapy for patients who receive drug-eluting stents may be the biggest cloud over the market for the devices, cardiologists suggest